Glaucoma Clinic Note: **/**/****    Glaucoma Diagnosis:   Referred by: Dr. *******  JOAG OD>OS    HPI: ***** * ******* is a 44 y.o. female    *** from Dr. ******* due to scheduling conflicts    6 week follow up  Good drop compliance. Denies eye pain. C/o dry eyes. Vision stable.     MD HPI: Diagnosed with OHT at young age. Was taken off drops for about 9 months due to "thick corneas" and have very elevated **** when she represented for an exam. Has had SLT and been on topical therapy since.    Eye medications:  Timolol Qam OU - 5:30am  Dorzolamide BID OU - 5:40am  Low-dose CBD at night for anxiety PRN     Current Medication List    Name Sig   DORZOLAMIDE 22.3 MG-TIMOLOL 6.8 MG/ML EYE DROPS Instill 1 drop into both eyes two times daily.   LATANOPROST 0.005 % EYE DROPS Instill 2 drops into both eyes once daily at bedtime.   TRAZODONE 150 MG TABLET Take 150 mg by mouth.       Glaucoma summary:   Referred in 2019 at age 44 for JOAG OD>OS    Other ocular diagnoses:     Ocular procedures:  OD OS   SLT */*/** Dr.****** *** */**/** Dr.******           **            **  *** IOP ~34 ~34   Pachymetry 608  602   Target IOP <21 <25   Diurnal none none     Glaucoma medications to avoid:   Latanoprost - no response    Family history of glaucoma? Yes- Father (dx ~40), Paternal Aunt (dx ~40)    History of eye trauma? No   Diabetes? No  Asthma/COPD? No  Hypotension/***** history? No  Migraines/Raynauds? No  Steroid use? Yes in the past  Kidney stones? No  Driving? Yes, day and night  Flomax use? Never  Anticoagulation? No     Occupation:  Surgical **** (****)    Review of systems: Significant for ophthalmic symptoms as per HPI. 12 review of systems (including constitutional symptoms, ENT, cardiovascular, respiratory, gastrointestinal, genitourinary, ************, neurologic, psychiatric, endocrine, hematologic, and immunologic) negative, except for eye symptoms    Past Medical History:   Diagnosis Date   • Insomnia    • Obesity    • PVC's (premature ventricular contractions)        Past Surgical History   Procedure Laterality Date   • Breast reduction  **/****   • Carpal tunnel release  2014   • Appendectomy  1996     l/s appy, non-ruptured   • Removal of tonsils and adenoids  1978   • Endometrial ablation  **/****     ******* ablation for menorrhagia       Allergies:   Patient has no known allergies.    Pt  reports that she has quit smoking. Her smoking use included cigarettes. She has never used smokeless tobacco. She reports current alcohol use of about 6.0 standard drinks of alcohol per week. She reports previous drug use.    Examination    Mental status: Alert and oriented x 3     VAsc              **** sc               VAcc            **** cc ***   OD 20/30-2 20/20-1         at     OS 20/20           at    Add       Motility:  Ortho in primary gaze, full OU    Slit lamp Exam    IOP: OD 19, OS 19 by Applanation at 3:33 PM.     Right Left   Gonioscopy (**/**/****)       Lids / Lashes Normal Normal   Conjunctiva / Sclera* ***** and quiet ***** and quiet   Cornea** All layers clear All layers clear   Anterior Chamber Deep and quiet Deep and quiet   **** Normal Normal   Lens Trace NS  Trace **   *Conjunctiva includes bulbar and palpebral, unless otherwise noted.  **Cornea includes epithelium, stroma and endothelium, unless otherwise noted.    Fundus exam Dilated with tropicamide 1% and phenylephrine 2.5% OU at ** ***** exists for the SDE: EPIC#******      Right Left   Disc Inferior undermining, intact superiorly, intact rim 0.7 intact rim, no heme 0.*   ****** **** ****   Vitreous       Periphery         Visual ***** Interpretation (*** */**/**)    Q15.0 OAG (open angle glaucoma), juvenile    Assessment and Plan    1. *** **>OS - in the setting of very thick CCT. She has glaucomatous optic neuropathy OD and intact ONH OS. She has had stable **** overall over the past few years with a dense superior arcuate/hemifield defect OD (sparing some of the superior paracentral vision). She is on 2 topical medications and s/p SLT. Given her thick CCT and overall stable **** in the past few years, would set a target IOP of <21 OD and <25 OS. Her optic neuropathy OD is likely to have occurred during her episodes of uncontrolled IOP when she was off topical drops.    Discussed treatments of JOAG, including drops, laser, surgery (trab vs. Tube implant)  Discussed autosomal dominant inheritance of JOAG (typically **** **** defect)  Discussed risks of passing **** on to children/grandchildren  D/C timolol   D/C dorzolamide   Start timolol/dorzolamide combination BID OU  RTC in 6 months for HVF 24-2 OU and DFE OU, sooner prn    Start of MD visit 3:35pm  End of MD visit 4:00pm  Greater than 50% of the encounter was spent in counseling the patient    The attending physician is responsible for and agrees with the entire content of the note and has personally performed the HPI and the physical examination.        ******* *******, MD, ***  ********* ********* of Ophthalmology  Glaucoma Service  ***** *** *********   ****** ****** * ******* **********        